Department of Pharmacy, College of Health Sciences, Al Jouf University, Sakaka, Al Jouf, Saudi Arabia.
Eur J Med Chem. 2009 Dec;44(12):4896-903. doi: 10.1016/j.ejmech.2009.08.001. Epub 2009 Aug 6.
A series of 6-aminomethyl-2-aryl-1-benzopyran-4-one derivatives (10-24) were synthesized. The compounds were tested for anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation actions. Among the tested compounds, six compounds 11, 13, 16, 18, 21 and 23 showed higher degree of anti-inflammatory activity (>75% activity of standard drug ibuprofen). In addition to remarkable anti-inflammatory activity, analgesic activity was found to be comparable with that of the standard drug ibuprofen. Compounds 16 and 21 showed a significant GI protection (with respect to ulcerogenesis) and a marked decrease in lipid peroxidation values whereas compounds 11 and 16 were found to possess antimicrobial activity against Staphylococcus aureus, Escherichia coli, Rhizopus oryza and Penicillum citrum with an MIC of 10 microg/mL.
一系列 6-氨甲基-2-芳基-1-苯并吡喃-4-酮衍生物(10-24)被合成。这些化合物被测试了抗炎、镇痛、溃疡形成和脂质过氧化作用。在所测试的化合物中,有 6 个化合物 11、13、16、18、21 和 23 表现出更高程度的抗炎活性(>标准药物布洛芬 75%的活性)。除了显著的抗炎活性外,镇痛活性也与标准药物布洛芬相当。化合物 16 和 21 表现出显著的 GI 保护(相对于溃疡形成)和脂质过氧化值的显著降低,而化合物 11 和 16 被发现对金黄色葡萄球菌、大肠杆菌、米根霉和青霉具有抗菌活性,MIC 为 10μg/mL。